Berlin Heart Patient

Berlin Heart EXCOR and ACTION Post-Approval Surveillance Study Report

Cerebrovascular accidents (CVA) are a common problem in pediatric VAD support. This Pedimacs analysis investigates rates, risk factors, and outcomes The field of pediatric mechanical circulatory support changed dramatically when the Berlin Heart EXCOR® VAD was FDA-approved for use in children nearly two decades ago. This ACTION publication describes the outcomes of patients with a Berlin […]

Berlin Heart EXCOR and ACTION Post-Approval Surveillance Study Report Read More »

Systemic VAD Support in Fontan Patients: A Report by ACTION

Fontan patients are at risk for developing significant heart failure. This retrospective study investigates the efficacy of VAD support in 45 Fontan patients—the first Fontan multi-center cohort from ACTION centers: “Systemic ventricular assist device support in Fontan patients: A report by ACTION.” It was published in The Journal of Heart and Lung Transplantation on January

Systemic VAD Support in Fontan Patients: A Report by ACTION Read More »

HVAD System

HVAD Usage and Outcomes in the Current Pediatric Ventricular Assist Device Field: An ACTION Analysis

“HVAD Usage and Outcomes in the Current Pediatric Ventricular Assist Device Field: An Advanced Cardiac Therapies Improving Outcomes Network Analysis” describes clinical outcomes in fifty pediatric patients implanted with the HVAD™ System at ACTION centers between April 2018-April 2020. The article shows excellent HVAD outcomes at ACTION centers and was published in ASAIO Journal on

HVAD Usage and Outcomes in the Current Pediatric Ventricular Assist Device Field: An ACTION Analysis Read More »

Variation in Cardiac Rehabilitation for Pediatric VAD Recipients Across North America

There is little standardization across pediatric heart failure centers when it comes to the use of exercise testing and cardiac rehabilitation (CR) after VAD placement. “Variation in Cardiac Rehabilitation for Pediatric Ventricular Assist Device Recipients Across North America” describes existing practice variations and identifies barriers to exercise testing and CR. This ACTION article, published in

Variation in Cardiac Rehabilitation for Pediatric VAD Recipients Across North America Read More »

Outcomes of Children Supported with Devices Labeled as “Temporary”

“Outcomes of children supported with devices labeled as “temporary” or short term: A report from the Pediatric Interagency Registry for Mechanical Circulatory Support” was published in The Journal of Heart and Lung Transplantation on Oct 31, 2017. When this report was published, the use of “temporary” VADs had expanded to include bridge to transplant, bridge

Outcomes of Children Supported with Devices Labeled as “Temporary” Read More »

Implantation of a Total Artificial Heart in a 10-Year-Old

“Implantation of total artificial heart in a 10-year-old after support with a temporary perventricular assist device” was published in The Journal of Thoracic and Cardiovascular Surgery on August 28, 2019. This report represents the youngest patient supported by a 50-cc SynCardia Total Artificial Heart (TAH-t) in the United States. It describes the successful use of

Implantation of a Total Artificial Heart in a 10-Year-Old Read More »

Iron Deficiency Is Associated with Adverse Outcomes in Pediatric Heart Failure

“Iron Deficiency Is Associated with Adverse Outcomes in Pediatric Heart Failure” was published in The Journal of Pediatrics on January 1, 2020. As the title suggests, this single-center retrospective cohort study revealed that iron deficiency in pediatric heart failure patients was associated with greater risk of ventricular assist device implantation, heart transplantation, or mortality. The

Iron Deficiency Is Associated with Adverse Outcomes in Pediatric Heart Failure Read More »

“Compassionate” Cases of the Jarvik 2015 VAD

The Jarvik 2015 VAD, the first and currently only continuous-flow VAD specifically designed for small children, is being assessed in the Pump for Kids, Infants, and Neonates (PumpKIN) trial. Inclusion criteria for this multicenter, prospective, single-arm feasibility study was strict. Patients who failed to meet the criteria received the Jarvik 2015 VAD under the designation

“Compassionate” Cases of the Jarvik 2015 VAD Read More »